Recurrent pregnancy loss and inappropriate local immune response to sex hormones

American Journal of Reproductive Immunology

Volumn 57, Issue 2, 2007, Pages 160-165

  Itsekson, Alek M ^a   Seidman, Daniel S ^a   Zolti, Matityahu ^a   Lazarov, Anneta ^b   Carp, Howard J A ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b MEIR MEDICAL CENTER   (Israel)

Author keywords

Estrogen; Progesterone; Recurrent miscarriage; Skin testing; Spontaneous abortion

Indexed keywords

ESTRADIOL; ESTROGEN; PROGESTERONE; SEX HORMONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERSENSITIVITY REACTION; IMMUNE RESPONSE; LONGITUDINAL STUDY; MEDICAL RESEARCH; PRIORITY JOURNAL; RECURRENT ABORTION; URTICARIA;

ABORTION, HABITUAL; ADULT; CASE-CONTROL STUDIES; ESTROGENS; FEMALE; GONADAL STEROID HORMONES; HUMANS; LONGITUDINAL STUDIES; PROGESTERONE; PROSPECTIVE STUDIES; SKIN TESTS;

EID: 33846223163     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2006.00461.x     Document Type: Article

References (51)

1. American College of Obstetricians and Gynecologists: ACOG practice bulletin. Management of recurrent pregnancy loss; Number 24, February 2001. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002; 78: 179-190.
2. Csapo AI, Pulkkinen MO: Indispensability of the human corpus luteum in the maintenance of early pregnancy: Lutectomy evidence. Obstet Gynecol Surv 1978; 3: 69-81.
3. Spitz IM, Bardin W, Benton L, Robbins A: Early pregnancy termination with mifepristone and misoprostol in the United States. N Eng J Med 1998; 338: 1241-1247.
4. Mishell DR, Jain JR, Byrne JD, Laccarra MDC: A Medical Method of early pregnancy termination using tamoxifen and misoprostol. Contraception 1998; 58: 1-30.
5. Horta JLH, Fernandez JG, DeSoto LB: Direct evidence of luteal insufficiency in women with habitual abortion. Obstet Gynecol 1977; 49: 705-708.
6. Noyes RW, Hertig AT, Rock J: Dating the endometrial biopsy. Fertil Steril 1950; 1: 3-10.
7. Herzberg AJ, Strohmeyer CR, Cirillo-Hyland VA: Autoimmune progesterone dermatitis. J Am Acad Dermatol 1995; 32: 335-338.
8. Cheesman KL, Gynor LV, Chatterton RT, Radvany RM: Identification of a 17-hydroprogesterone-binding immunoglobulin in the serum of a woman with periodic rashes. J Clin Endocrinol Metab 1982; 55: 597-599.
9. Bierman SM: Autoimmune progesterone dermatitis of pregnancy. Arch Dermatol 1973; 107: 896-901.
10. Wojnarowska F, Greaves MW, Peachey RDG: Progesterone-induced erythema multiforme. J R Soc Med 1985; 78: 407-408.
11. Stephens CMJ, Wojnarowska F, Wilkinson JD: Autoimmune progesterone dermatitis responding to tamoxifen. Br J Dermatol 1989; 121: 135-137.
12. Shelley WB, Shelley ED, Talanin NR: Estrogen dermatitis. J Am Acad Derm 1995; 32: 25-31.
13. Yotsumoto S, Shimomai K, Hashiguchi T, Uchimiya H, Usuki K, Nishi M, Kanekura T, KanAaki T: Estrogen dermatitis: a dendritic-cell-mediated allergic condition. Dermatology 2003; 207: 265-268.
14. Itsekson A, Lazarov A, Cordoba M, Zeityni M, Abraham D, Seidman D: Hypersensitivity to female sex hormones in patients with premenstrual syndrome and skin disease. J Reprod Med 2004; 49: 195-199.
15. Schoenmakers A, Vermorken A, DeGreef H, Dooms-Goossens A: Corticosteroid or steroid allergy? Contact Dermatitis 1992; 26: 159-162.
16. Wilkinson SM, Beck MH: The significance of positive patch tests to 17-hydroxyprogesterone. Contact Dermatitis 1994; 30: 302-303.
17. Beaumont V, Malinov MR, Sexton A: Hyperhomocystinemia, anti-estrogen antibodies and other risk factors for thrombosis in women on oral contraceptives. Atherosclerosis 1992; 94: 147-152.
18. Beagley KW, Gockel CM: Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol Med Microbiol 2003; 38: 13-22.
19. Gleicher N, El-Roeiy A, Confino E, Friberg J: Autoantibodies in reproductive failure: Is endometriosis an auto-immune disease? Obstet Gynecol 1987; 70: 15-22.
20. LaBarbera AR, Miller MM, Ober C, Rebar RW: Autoimmune etiology in premature ovarian failure. Am J Reprod Immunol 1988; 16: 115-122.
21. Taylor PV, Campbell JM, Scott JS: Presence of autoantibodies in women with unexplained infertility. Am J Obstet Gynecol 1989; 161: 377-379.
22. Geva E, Yaron Y, Lessing JB: Circulating autoimmune antibodies may be responsible for implantation failure in in vitro fertilization. Fertil Steril 1994; 62: 802-806.
23. Cowchock S, Smith JB, Gocial S: Antibodies to phospholipids and nuclear antigens in patients with related abortions. Am J Obstet Gynecol 1995; 155: 1002-1010.
24. Davis DL: Environmental influences on breast cancer risk. Sci Med 1997; 4: 56.
25. Jacobson JL, Jacobson SW: Intellectual impairment in children exposed to polychlorinated biphenyls in utero. N Engl J Med 1996; 335: 783-789.
26. TeeluckAingh S, Edwards CRW: Case report: autoimmune progesterone dermatitis. J Intern Med 1990; 227: 143-144.
27. Case AM, Reid RL: Menstrual cycle effects on common medical conditions. Compr Ther 2001; 27: 65-71.
28. Rodenas JM, Herranz MT, Tercedor J: Autoimmune progesterone dermatitis: treatment with oophorectomy. Br J Dermatol 1998; 139: 508-511.
29. Wilkinson SM, Beck MH, Kingston TP: Progesterone-induced urticaria - need it be autoimmune? Br J Dermatol 1995; 133: 792-794.
30. Govorukhina EM: Principles of pathogenetic treatment of spontaneous cyclic abdominal pain in women. Sov Med 1991; 4: 3-26 (in Russian).
31. Roby RR, Richardson RH, Vojdani A: Hormone allergy. Am J Reprod Immunol 2006; 55: 307-313.
32. Slater JE, Raphael G, Gulter GB: Recurrent anaphylaxis in menstruating women: Treatment with a luteinizing hormone-releasing agonist. A preliminary report. Obstet Gynecol 1987; 70: 592-596.
33. Hiura T, Matsuda M, Yanbe H, Sugiyama S: Two cases of autoimmune progesterone dermatitis. Immunohistochemical and serological studies. Acta Derm Venereal (Stockh) 1989; 69: 308-310.
34. Gleicher N, el-Roeiy A: The reproductive autoimmune failure syndrome. Am J Obstet Gynecol 1988; 159: 223-227.
35. Matzner W, Chong P, Xu G, Ching W: Characterization of antiphospholipid antibodies in women with recurrent spontaneous abortions. J Reprod Med 1994; 39: 27-30.
36. Sills ES, Conway SC, Kaplan CR, Perloe M, Tucker MJ: First successful case of in vitro fertilization-embryo transfer with venom immunotherapy for hymenoptera sting allergy. Clin Mol Allergy 2004; 19: 2-11.
37. Aoki K, Kajiura S, Matsumoto Y, Ogasawara M, Okada S, Yagami Y, Gleicher N: Preconceptional natural-killer-cell activity as a predictor of miscarriage. Lancet 1995; 345: 1340-1342.
38. Clifford K, Flanagan AM, Regan L: Endometrial CD56+ natural killer cells in women with recurrent miscarriage: A histomorphometric study. Hum Reprod 1999; 14: 2727-2730.
39. Coulam CB, Beaman KD: Reciprocal alteration in circulating TJ6+ CD19+ and TJ6+ CD56+ leukocytes in early pregnancy predicts success or miscarriage. Am J Reprod Immunol 1995; 34: 219-224.
40. Kruse C, Varming K, Christiansen OB: Prospective, serial investigations of in-vitro lymphocyte cytokine production, CD62L expression and proliferative response to microbial antigens in women with recurrent miscarriage. Hum Reprod 2003; 18: 2465-2472.
41. Mabray CR, Burditt ML, Martin JL: Treatment of common gynecologic-endocrinologic symptoms by allergy management procedures. Obstet Gynecol 1982; 59: 560-564.
42. Jutel M, Pichler WJ, Skrbic D: Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures. J Immunol 1995; 154: 4187-4194.
43. Secrist H, Chelen CJ, Wen Y: Allergen immununotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 1993; 178: 2123-2130.
44. Varney VA, Hamid QA, Gaga M: Influence of grass pollen immunotherapy on cellular infiltration and cytokine rnRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 1993; 92: 644-651.
45. Daya S: Ovulation induction for curpus luteum deficiency. Semin Reprod Endocrinol 1990; 8: 156-164.
46. Jones WR: Vaccination for contraception. Aust N Z J Obstet Gynaecol 1994; 34: 320-329.
47. Carp HJA, Toder V, Orgad S, Aviram A, Danieli M, Mashiach S, Barkai G: Karyotype of the abortus in recurrent miscarriage. Fertil Steril 2001; 5: 678-682.
48. Ogasawara M, Aoki K, Okada S, Suzumori K: Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril 2000; 73: 300-304.
49. Stephenson MD, Awartani KA, Robinson WP: Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: A case-control study. Hum Reprod 2002; 17: 446-451.
50. Stern JJ, Dorfman AD, Gutierez-Najar MD: Frequency of abnormal karyotype among abortuses from women with and without a history of recurrent spontaneous abortion. Fertil Steril 1996; 65: 250-253.
51. Sullivan AE, Silver RM, LaCoursiere DY, Porter TF, Branch DW: Recurrent fetal aneuploidy and recurrent miscarriage. Obstet Gynecol 2004; 104: 784-788.